24 results
424B3
MEIP
MEI Pharma Inc
6 Jun 23
Prospectus supplement
4:19pm
(“FDORA”), Congress required sponsors to develop and submit a diversity action plan for each phase 3 clinical trial or any other “pivotal study” of a new … , and an explanation of how the sponsor intends to meet them. In addition to these requirements, the legislation directs the FDA to issue new guidance on diversity
424B3
1cwxo
27 Sep 13
Prospectus supplement
12:00am
424B3
4uuhz50k2tef
19 Sep 13
Prospectus supplement
12:00am